BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33208304)

  • 1. FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease.
    Alderawi A; Caramori G; Baker EH; Hitchings AW; Rahman I; Rossios C; Adcock I; Cassolari P; Papi A; Ortega VE; Curtis JL; Dunmore S; Kirkham P
    BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33208304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Potential Role for Fructosamine-3-Kinase in Cataract Treatment.
    De Bruyne S; van Schie L; Himpe J; De Somer F; Everaert I; Derave W; Van den Broecke C; Huizing M; Bostan N; Speeckaert M; Callewaert N; Van Aken E; Delanghe JR
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new HPLC-based assay for the measurement of fructosamine-3-kinase (FN3K) and FN3K-related protein activity in human erythrocytes.
    Hellwig A; Scherber A; Koehler C; Hanefeld M; Henle T
    Clin Chem Lab Med; 2014 Jan; 52(1):93-101. PubMed ID: 23648633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
    Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
    Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
    Conner JR; Beisswenger PJ; Szwergold BS
    Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.
    Delplanque J; Delpierre G; Opperdoes FR; Van Schaftingen E
    J Biol Chem; 2004 Nov; 279(45):46606-13. PubMed ID: 15331600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life.
    Black-Shinn JL; Kinney GL; Wise AL; Regan EA; Make B; Krantz MJ; Barr RG; Murphy JR; Lynch D; Silverman EK; Crapo JD; Hokanson JE;
    COPD; 2014 Sep; 11(5):546-51. PubMed ID: 24831864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
    Mosca L; Penco S; Patrosso MC; Marocchi A; Lapolla A; Sartore G; Chilelli NC; Paleari R; Mosca A
    Clin Chem Lab Med; 2011 May; 49(5):803-8. PubMed ID: 21288167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
    Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
    Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.
    Avemaria F; Carrera P; Lapolla A; Sartore G; Chilelli NC; Paleari R; Ambrosi A; Ferrari M; Mosca A
    Clin Chem Lab Med; 2015 Aug; 53(9):1315-20. PubMed ID: 26352355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased protein glycation in fructosamine 3-kinase-deficient mice.
    Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
    Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.
    Lutz SM; Frederiksen B; Begum F; McDonald MN; Cho MH; Hobbs BD; Parker MM; DeMeo DL; Hersh CP; Ehringer MA; Young K; Jiang L; Foreman MG; Kinney GL; Make BJ; Lomas DA; Bakke P; Gulsvik A; Crapo JD; Silverman EK; Beaty TH; Hokanson JE;
    Nicotine Tob Res; 2019 May; 21(6):714-722. PubMed ID: 29767774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities.
    Nikolaou V; Massaro S; Garn W; Fakhimi M; Stergioulas L; Price D
    Respir Med; 2021 Sep; 186():106528. PubMed ID: 34260974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in chronic obstructive pulmonary disease.
    Maclay JD; McAllister DA; Macnee W
    Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
    Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
    BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of Cardiovascular Comorbidity in COPD in a Country with Low-smoking Prevalence: Results from Two-population-based Cohorts from Sweden.
    Eriksson B; Backman H; Ekerljung L; Axelsson M; Lindberg A; Rönmark E; Lundbäck B
    COPD; 2018 Oct; 15(5):454-463. PubMed ID: 30475654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.